ArticlePloS one2018

The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy.

Pablo F Barcelona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.